EVP, Innovative Medicine, R&D
Avg Cost/Share
$243.00
Shares
53,931
Total Value
$13,105,233.00
Owned After
12,941
EVP, Innovative Medicine, R&D
Avg Cost/Share
$192.71
Shares
21,721
Total Value
$4,185,793.09
Owned After
12,941
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| REED JOHN C | JNJ | EVP, Innovative Medicine, R&D | Feb 17, 2026 | Sell | $243.00 | 53,931 | $13,105,233.00 | 12,941 | |
| REED JOHN C | JNJ | EVP, Innovative Medicine, R&D | Oct 17, 2025 | Sell | $192.71 | 21,721 | $4,185,793.09 | 12,941 |